Elan hit after drug linked to brain disease
August 4th, 2008 by 
admin Drugmaker’s shares halve in continuance after directive sort is linked to potentially fatal disease. Tysabri was authorised for communication for MS sufferers in the US and in aggregation but condemned soured the US mart in 2005
Posted in Pharmaceuticals | 